Metraipolis › archive › dc_8a12d6f5341e

The clinical utility of autoantibodies in systemic sclerosis: a review with a focus on cohort differences and standardization — Europe PMC PMID:41208971

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41208971
DOI
10.3389/fimmu.2025.1691988
License (as archived)
solo-consultazione
Archived
2026-11-09T01:50:03.651Z
SHA-256 of the archived text
0c55133de48ec46e2e96ec5781af90f728b84701f1152e64c315b72a319b4f24
Stable URL of this page
https://metraipolis.com/documento/dc_8a12d6f5341e

How to cite

The clinical utility of autoantibodies in systemic sclerosis: a review with a focus on cohort differences and standardization — Europe PMC PMID:41208971 — Europe PMC (en), https://europepmc.org/article/MED/41208971 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a12d6f5341e (Metraipolis archive dc_8a12d6f5341e, sha256 0c55133de48ec46e2e96ec5781af90f728b84701f1152e64c315b72a319b4f24)
BibTeX
@misc{dc8a12d6f5341e,
  title = {The clinical utility of autoantibodies in systemic sclerosis: a review with a focus on cohort differences and standardization — Europe PMC PMID:41208971},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41208971},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a12d6f5341e; sha256 0c55133de48ec46e2e96ec5781af90f728b84701f1152e64c315b72a319b4f24},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41208971. Agents can read the archived copy with the MCP tool read_document.